Between the Guidelines: Variability in Management of Patients With Cystic Fibrosis and Dysglycemia
Authors' conclusion
This survey of US endocrinologists with CF expertise offers valuable insight into current practices for managing pre-CFRD, while highlighting considerable variation in clinical practice. Respondents agreed on key long-term outcomes as priorities for future care, but management differed regarding use and choice of diagnostic tools and medications.
Study context
- Population
- US-based endocrinologists, current or former participants in the EnVision-CF Program, managing pre-CFRD dysglycemia in people with cystic fibrosis (CF) without diabetes
- Outcome
- Pre-CFRD management practices
Methodological details34-question survey, quantitative and qualitative analysis, descriptive
- 34-question survey
- Quantitative and qualitative analysis
- Descriptive
Main finding
As reported in the abstract
Treatment option: basal insulin alone
75%
Treatment option: bolus insulin alone
60%
Observational data: associations, not effects.
Original publication
Between the Guidelines: Variability in Management of Patients With Cystic Fibrosis and Dysglycemia. Endocr Pract. Published 27 March 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →